Anti-Sialyl-di-Lewis^a CAR T cells for effective anti-tumour therapy of gastrointestinal tumours

Iniobong Charles, Katherine Cook, Bubacarr Kaira, Gaëlle Cane, Anne Skinner, Alissa Wright, Mireille Vankemmelbeke, Rachael Metheringham, Victoria Brentville and Lindy Durrant

Glymab® ADC’s for targeting cancers with high unmet need Fucosyl-GM1 and Lewis^Y : internalising targets for SCLC and multiple solid tumours

Bryony Heath, Elena Dubinina, Foram Dave, Ruhul H. Choudhury, Omar Mohammed, Bubacarr Kaira, Poonam Vaghela, Tina Parsons, Mandeep Sehmi, Mireille Vankemmelbeke and Lindy G. Durrant

GlyMabs® for T cell redirection

Anti-sialyl-di-lewis^a CAR T cells for effective anti-tumour therapy

Iniobong Charles, Katherine Cook, Bubacarr Kaira, Gaëlle Cane, Anne Skinner, Alissa Wright, Mireille Vankemmelbeke, Rachael Metheringham, Victoria Brentville and Lindy Durrant